Loratadine And Pseudoephedrine Sulfate 62037-0605-08
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- February 21, 2003
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Loratadine | 10 mg/1 |
| Pseudoephedrine Sulfate | 240 mg/1 |
Selected Package
62037-0605-08Selected10638 TABLET, EXTENDED RELEASE in 1 BOX (62037-605-08)